nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—CYP19A1—esophageal cancer	0.764	1	CbGaD
Anastrozole—CYP2C9—Capecitabine—esophageal cancer	0.0235	0.665	CbGbCtD
Anastrozole—CYP2C9—Cisplatin—esophageal cancer	0.0119	0.335	CbGbCtD
Anastrozole—Hepatic pain—Capecitabine—esophageal cancer	0.00862	0.0692	CcSEcCtD
Anastrozole—Retinal vein thrombosis—Methotrexate—esophageal cancer	0.0051	0.0409	CcSEcCtD
Anastrozole—Hepatitis acute—Methotrexate—esophageal cancer	0.00369	0.0296	CcSEcCtD
Anastrozole—Mood alteration NOS—Capecitabine—esophageal cancer	0.00358	0.0287	CcSEcCtD
Anastrozole—Lymphoedema—Capecitabine—esophageal cancer	0.00294	0.0236	CcSEcCtD
Anastrozole—Thromboembolic event—Capecitabine—esophageal cancer	0.00267	0.0214	CcSEcCtD
Anastrozole—Mood alteration NOS—Methotrexate—esophageal cancer	0.00267	0.0214	CcSEcCtD
Anastrozole—Coronary artery disease—Cisplatin—esophageal cancer	0.00247	0.0198	CcSEcCtD
Anastrozole—Joint stiffness—Capecitabine—esophageal cancer	0.00238	0.0191	CcSEcCtD
Anastrozole—Thromboembolic event—Methotrexate—esophageal cancer	0.00199	0.0159	CcSEcCtD
Anastrozole—Hepatotoxicity—Cisplatin—esophageal cancer	0.00126	0.0101	CcSEcCtD
Anastrozole—Ageusia—Cisplatin—esophageal cancer	0.0012	0.00966	CcSEcCtD
Anastrozole—Infection—Carboplatin—esophageal cancer	0.00118	0.00945	CcSEcCtD
Anastrozole—Raised liver function tests—Methotrexate—esophageal cancer	0.00116	0.0093	CcSEcCtD
Anastrozole—Embolism—Capecitabine—esophageal cancer	0.00112	0.00898	CcSEcCtD
Anastrozole—Hypercalcaemia—Capecitabine—esophageal cancer	0.00103	0.0083	CcSEcCtD
Anastrozole—Ulcer—Cisplatin—esophageal cancer	0.00103	0.00827	CcSEcCtD
Anastrozole—Thrombosis—Capecitabine—esophageal cancer	0.00102	0.00815	CcSEcCtD
Anastrozole—Pain—Carboplatin—esophageal cancer	0.00101	0.00814	CcSEcCtD
Anastrozole—Blister—Capecitabine—esophageal cancer	0.000997	0.008	CcSEcCtD
Anastrozole—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.000971	0.00779	CcSEcCtD
Anastrozole—Osteoporosis—Methotrexate—esophageal cancer	0.000954	0.00766	CcSEcCtD
Anastrozole—Body temperature increased—Carboplatin—esophageal cancer	0.000937	0.00752	CcSEcCtD
Anastrozole—Hepatotoxicity—Capecitabine—esophageal cancer	0.00093	0.00747	CcSEcCtD
Anastrozole—Multiple fractures—Methotrexate—esophageal cancer	0.00092	0.00739	CcSEcCtD
Anastrozole—Fracture—Methotrexate—esophageal cancer	0.00092	0.00739	CcSEcCtD
Anastrozole—Neuropathy—Cisplatin—esophageal cancer	0.000915	0.00735	CcSEcCtD
Anastrozole—Myocardial ischaemia—Capecitabine—esophageal cancer	0.000894	0.00717	CcSEcCtD
Anastrozole—Ageusia—Capecitabine—esophageal cancer	0.000887	0.00712	CcSEcCtD
Anastrozole—Vaginal discharge—Methotrexate—esophageal cancer	0.000879	0.00706	CcSEcCtD
Anastrozole—Embolism—Methotrexate—esophageal cancer	0.000833	0.00669	CcSEcCtD
Anastrozole—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.000801	0.00643	CcSEcCtD
Anastrozole—Cyst—Methotrexate—esophageal cancer	0.0008	0.00642	CcSEcCtD
Anastrozole—Ulcer—Capecitabine—esophageal cancer	0.00076	0.0061	CcSEcCtD
Anastrozole—Cataract—Capecitabine—esophageal cancer	0.000755	0.00606	CcSEcCtD
Anastrozole—Bone pain—Capecitabine—esophageal cancer	0.00075	0.00602	CcSEcCtD
Anastrozole—Inflammation—Capecitabine—esophageal cancer	0.000741	0.00595	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000731	0.00587	CcSEcCtD
Anastrozole—Neck pain—Capecitabine—esophageal cancer	0.000727	0.00584	CcSEcCtD
Anastrozole—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000722	0.0058	CcSEcCtD
Anastrozole—Pulmonary embolism—Capecitabine—esophageal cancer	0.000718	0.00577	CcSEcCtD
Anastrozole—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000718	0.00577	CcSEcCtD
Anastrozole—Influenza like illness—Capecitabine—esophageal cancer	0.000698	0.0056	CcSEcCtD
Anastrozole—Hepatotoxicity—Methotrexate—esophageal cancer	0.000693	0.00556	CcSEcCtD
Anastrozole—Neuropathy—Capecitabine—esophageal cancer	0.000675	0.00541	CcSEcCtD
Anastrozole—Neoplasm—Capecitabine—esophageal cancer	0.00065	0.00521	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000637	0.00511	CcSEcCtD
Anastrozole—Thrombophlebitis—Capecitabine—esophageal cancer	0.000602	0.00484	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.0006	0.00481	CcSEcCtD
Anastrozole—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.000596	0.00479	CcSEcCtD
Anastrozole—Sweating increased—Cisplatin—esophageal cancer	0.000596	0.00478	CcSEcCtD
Anastrozole—Swelling—Capecitabine—esophageal cancer	0.000591	0.00475	CcSEcCtD
Anastrozole—Ulcer—Methotrexate—esophageal cancer	0.000565	0.00454	CcSEcCtD
Anastrozole—Hot flush—Capecitabine—esophageal cancer	0.000558	0.00448	CcSEcCtD
Anastrozole—Increased appetite—Capecitabine—esophageal cancer	0.000555	0.00446	CcSEcCtD
Anastrozole—Menopausal symptoms—Capecitabine—esophageal cancer	0.000553	0.00444	CcSEcCtD
Anastrozole—Inflammation—Methotrexate—esophageal cancer	0.000551	0.00443	CcSEcCtD
Anastrozole—Dermatitis bullous—Capecitabine—esophageal cancer	0.000546	0.00438	CcSEcCtD
Anastrozole—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000537	0.00431	CcSEcCtD
Anastrozole—Arthritis—Capecitabine—esophageal cancer	0.000537	0.00431	CcSEcCtD
Anastrozole—Vaginal inflammation—Methotrexate—esophageal cancer	0.000535	0.00429	CcSEcCtD
Anastrozole—Pulmonary embolism—Methotrexate—esophageal cancer	0.000535	0.00429	CcSEcCtD
Anastrozole—Myocardial infarction—Cisplatin—esophageal cancer	0.000534	0.00429	CcSEcCtD
Anastrozole—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000534	0.00429	CcSEcCtD
Anastrozole—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000532	0.00427	CcSEcCtD
Anastrozole—Lethargy—Capecitabine—esophageal cancer	0.000532	0.00427	CcSEcCtD
Anastrozole—Osteoarthritis—Capecitabine—esophageal cancer	0.000522	0.00419	CcSEcCtD
Anastrozole—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000516	0.00414	CcSEcCtD
Anastrozole—Vaginal infection—Methotrexate—esophageal cancer	0.000505	0.00405	CcSEcCtD
Anastrozole—Mood swings—Capecitabine—esophageal cancer	0.000494	0.00397	CcSEcCtD
Anastrozole—Neoplasm—Methotrexate—esophageal cancer	0.000484	0.00388	CcSEcCtD
Anastrozole—Liver function test abnormal—Capecitabine—esophageal cancer	0.000481	0.00387	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.00047	0.00377	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00046	0.00369	CcSEcCtD
Anastrozole—Dysphagia—Capecitabine—esophageal cancer	0.000451	0.00362	CcSEcCtD
Anastrozole—Influenza—Capecitabine—esophageal cancer	0.000451	0.00362	CcSEcCtD
Anastrozole—Thrombophlebitis—Methotrexate—esophageal cancer	0.000448	0.0036	CcSEcCtD
Anastrozole—Angina pectoris—Capecitabine—esophageal cancer	0.000439	0.00352	CcSEcCtD
Anastrozole—Sweating increased—Capecitabine—esophageal cancer	0.000439	0.00352	CcSEcCtD
Anastrozole—Bronchitis—Capecitabine—esophageal cancer	0.000434	0.00348	CcSEcCtD
Anastrozole—Alopecia—Cisplatin—esophageal cancer	0.000433	0.00347	CcSEcCtD
Anastrozole—Erythema—Cisplatin—esophageal cancer	0.000426	0.00342	CcSEcCtD
Anastrozole—Weight increased—Capecitabine—esophageal cancer	0.00041	0.00329	CcSEcCtD
Anastrozole—Weight decreased—Capecitabine—esophageal cancer	0.000408	0.00327	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000401	0.00322	CcSEcCtD
Anastrozole—Depression—Capecitabine—esophageal cancer	0.000401	0.00322	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000398	0.0032	CcSEcCtD
Anastrozole—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000396	0.00318	CcSEcCtD
Anastrozole—Lethargy—Methotrexate—esophageal cancer	0.000396	0.00318	CcSEcCtD
Anastrozole—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000396	0.00318	CcSEcCtD
Anastrozole—Ill-defined disorder—Cisplatin—esophageal cancer	0.000395	0.00317	CcSEcCtD
Anastrozole—Myocardial infarction—Capecitabine—esophageal cancer	0.000394	0.00316	CcSEcCtD
Anastrozole—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000394	0.00316	CcSEcCtD
Anastrozole—Anaemia—Cisplatin—esophageal cancer	0.000394	0.00316	CcSEcCtD
Anastrozole—Jaundice—Capecitabine—esophageal cancer	0.000392	0.00314	CcSEcCtD
Anastrozole—Urinary tract infection—Capecitabine—esophageal cancer	0.000391	0.00314	CcSEcCtD
Anastrozole—Osteoarthritis—Methotrexate—esophageal cancer	0.000388	0.00312	CcSEcCtD
Anastrozole—Malaise—Cisplatin—esophageal cancer	0.000384	0.00308	CcSEcCtD
Anastrozole—Leukopenia—Cisplatin—esophageal cancer	0.000381	0.00306	CcSEcCtD
Anastrozole—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00038	0.00305	CcSEcCtD
Anastrozole—Mood swings—Methotrexate—esophageal cancer	0.000368	0.00295	CcSEcCtD
Anastrozole—Myalgia—Cisplatin—esophageal cancer	0.000363	0.00291	CcSEcCtD
Anastrozole—Haemoglobin—Capecitabine—esophageal cancer	0.000363	0.00291	CcSEcCtD
Anastrozole—Rhinitis—Capecitabine—esophageal cancer	0.000362	0.0029	CcSEcCtD
Anastrozole—Anxiety—Cisplatin—esophageal cancer	0.000361	0.0029	CcSEcCtD
Anastrozole—Haemorrhage—Capecitabine—esophageal cancer	0.000361	0.0029	CcSEcCtD
Anastrozole—Hepatitis—Capecitabine—esophageal cancer	0.000361	0.0029	CcSEcCtD
Anastrozole—Liver function test abnormal—Methotrexate—esophageal cancer	0.000358	0.00288	CcSEcCtD
Anastrozole—Discomfort—Cisplatin—esophageal cancer	0.000358	0.00288	CcSEcCtD
Anastrozole—Pharyngitis—Capecitabine—esophageal cancer	0.000358	0.00287	CcSEcCtD
Anastrozole—Oedema peripheral—Capecitabine—esophageal cancer	0.000355	0.00285	CcSEcCtD
Anastrozole—Oedema—Cisplatin—esophageal cancer	0.000348	0.00279	CcSEcCtD
Anastrozole—Anaphylactic shock—Cisplatin—esophageal cancer	0.000348	0.00279	CcSEcCtD
Anastrozole—Infection—Cisplatin—esophageal cancer	0.000345	0.00277	CcSEcCtD
Anastrozole—Erythema multiforme—Capecitabine—esophageal cancer	0.000341	0.00274	CcSEcCtD
Anastrozole—Hyperhidrosis—Cisplatin—esophageal cancer	0.000336	0.0027	CcSEcCtD
Anastrozole—Anorexia—Cisplatin—esophageal cancer	0.000331	0.00266	CcSEcCtD
Anastrozole—Alopecia—Capecitabine—esophageal cancer	0.000319	0.00256	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000317	0.00254	CcSEcCtD
Anastrozole—Erythema—Capecitabine—esophageal cancer	0.000314	0.00252	CcSEcCtD
Anastrozole—Paraesthesia—Cisplatin—esophageal cancer	0.000312	0.00251	CcSEcCtD
Anastrozole—Dyspnoea—Cisplatin—esophageal cancer	0.00031	0.00249	CcSEcCtD
Anastrozole—Dysgeusia—Capecitabine—esophageal cancer	0.000308	0.00247	CcSEcCtD
Anastrozole—Back pain—Capecitabine—esophageal cancer	0.000304	0.00244	CcSEcCtD
Anastrozole—Decreased appetite—Cisplatin—esophageal cancer	0.000302	0.00243	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0003	0.00241	CcSEcCtD
Anastrozole—Depression—Methotrexate—esophageal cancer	0.000298	0.00239	CcSEcCtD
Anastrozole—Pain—Cisplatin—esophageal cancer	0.000297	0.00239	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000297	0.00238	CcSEcCtD
Anastrozole—Ill-defined disorder—Capecitabine—esophageal cancer	0.000291	0.00234	CcSEcCtD
Anastrozole—Anaemia—Capecitabine—esophageal cancer	0.00029	0.00233	CcSEcCtD
Anastrozole—Sweating—Methotrexate—esophageal cancer	0.000287	0.0023	CcSEcCtD
Anastrozole—Feeling abnormal—Cisplatin—esophageal cancer	0.000287	0.0023	CcSEcCtD
Anastrozole—Malaise—Capecitabine—esophageal cancer	0.000283	0.00227	CcSEcCtD
Anastrozole—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000283	0.00227	CcSEcCtD
Anastrozole—Leukopenia—Capecitabine—esophageal cancer	0.000281	0.00226	CcSEcCtD
Anastrozole—Body temperature increased—Cisplatin—esophageal cancer	0.000275	0.00221	CcSEcCtD
Anastrozole—Cough—Capecitabine—esophageal cancer	0.000274	0.0022	CcSEcCtD
Anastrozole—Hypertension—Capecitabine—esophageal cancer	0.000271	0.00218	CcSEcCtD
Anastrozole—Haemoglobin—Methotrexate—esophageal cancer	0.00027	0.00217	CcSEcCtD
Anastrozole—Hepatitis—Methotrexate—esophageal cancer	0.000269	0.00216	CcSEcCtD
Anastrozole—Haemorrhage—Methotrexate—esophageal cancer	0.000269	0.00216	CcSEcCtD
Anastrozole—Arthralgia—Capecitabine—esophageal cancer	0.000267	0.00215	CcSEcCtD
Anastrozole—Myalgia—Capecitabine—esophageal cancer	0.000267	0.00215	CcSEcCtD
Anastrozole—Chest pain—Capecitabine—esophageal cancer	0.000267	0.00215	CcSEcCtD
Anastrozole—Pharyngitis—Methotrexate—esophageal cancer	0.000267	0.00214	CcSEcCtD
Anastrozole—Anxiety—Capecitabine—esophageal cancer	0.000266	0.00214	CcSEcCtD
Anastrozole—Discomfort—Capecitabine—esophageal cancer	0.000264	0.00212	CcSEcCtD
Anastrozole—Dry mouth—Capecitabine—esophageal cancer	0.000262	0.0021	CcSEcCtD
Anastrozole—Confusional state—Capecitabine—esophageal cancer	0.000258	0.00207	CcSEcCtD
Anastrozole—Oedema—Capecitabine—esophageal cancer	0.000256	0.00206	CcSEcCtD
Anastrozole—Hypersensitivity—Cisplatin—esophageal cancer	0.000256	0.00206	CcSEcCtD
Anastrozole—Infection—Capecitabine—esophageal cancer	0.000255	0.00204	CcSEcCtD
Anastrozole—Erythema multiforme—Methotrexate—esophageal cancer	0.000254	0.00204	CcSEcCtD
Anastrozole—Asthenia—Cisplatin—esophageal cancer	0.000249	0.002	CcSEcCtD
Anastrozole—Hyperhidrosis—Capecitabine—esophageal cancer	0.000248	0.00199	CcSEcCtD
Anastrozole—Anorexia—Capecitabine—esophageal cancer	0.000244	0.00196	CcSEcCtD
Anastrozole—Diarrhoea—Cisplatin—esophageal cancer	0.000238	0.00191	CcSEcCtD
Anastrozole—Alopecia—Methotrexate—esophageal cancer	0.000237	0.00191	CcSEcCtD
Anastrozole—Erythema—Methotrexate—esophageal cancer	0.000234	0.00188	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000234	0.00187	CcSEcCtD
Anastrozole—Insomnia—Capecitabine—esophageal cancer	0.000232	0.00186	CcSEcCtD
Anastrozole—Paraesthesia—Capecitabine—esophageal cancer	0.00023	0.00185	CcSEcCtD
Anastrozole—Dysgeusia—Methotrexate—esophageal cancer	0.000229	0.00184	CcSEcCtD
Anastrozole—Dyspnoea—Capecitabine—esophageal cancer	0.000229	0.00183	CcSEcCtD
Anastrozole—Back pain—Methotrexate—esophageal cancer	0.000226	0.00182	CcSEcCtD
Anastrozole—Dyspepsia—Capecitabine—esophageal cancer	0.000226	0.00181	CcSEcCtD
Anastrozole—Decreased appetite—Capecitabine—esophageal cancer	0.000223	0.00179	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000221	0.00178	CcSEcCtD
Anastrozole—Vomiting—Cisplatin—esophageal cancer	0.000221	0.00177	CcSEcCtD
Anastrozole—Fatigue—Capecitabine—esophageal cancer	0.000221	0.00177	CcSEcCtD
Anastrozole—Rash—Cisplatin—esophageal cancer	0.000219	0.00176	CcSEcCtD
Anastrozole—Constipation—Capecitabine—esophageal cancer	0.000219	0.00176	CcSEcCtD
Anastrozole—Pain—Capecitabine—esophageal cancer	0.000219	0.00176	CcSEcCtD
Anastrozole—Dermatitis—Cisplatin—esophageal cancer	0.000219	0.00176	CcSEcCtD
Anastrozole—Ill-defined disorder—Methotrexate—esophageal cancer	0.000217	0.00174	CcSEcCtD
Anastrozole—Anaemia—Methotrexate—esophageal cancer	0.000216	0.00173	CcSEcCtD
Anastrozole—Feeling abnormal—Capecitabine—esophageal cancer	0.000211	0.0017	CcSEcCtD
Anastrozole—Malaise—Methotrexate—esophageal cancer	0.000211	0.00169	CcSEcCtD
Anastrozole—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00021	0.00168	CcSEcCtD
Anastrozole—Leukopenia—Methotrexate—esophageal cancer	0.000209	0.00168	CcSEcCtD
Anastrozole—Nausea—Cisplatin—esophageal cancer	0.000207	0.00166	CcSEcCtD
Anastrozole—Cough—Methotrexate—esophageal cancer	0.000204	0.00164	CcSEcCtD
Anastrozole—Urticaria—Capecitabine—esophageal cancer	0.000204	0.00163	CcSEcCtD
Anastrozole—Abdominal pain—Capecitabine—esophageal cancer	0.000203	0.00163	CcSEcCtD
Anastrozole—Body temperature increased—Capecitabine—esophageal cancer	0.000203	0.00163	CcSEcCtD
Anastrozole—Myalgia—Methotrexate—esophageal cancer	0.000199	0.0016	CcSEcCtD
Anastrozole—Arthralgia—Methotrexate—esophageal cancer	0.000199	0.0016	CcSEcCtD
Anastrozole—Chest pain—Methotrexate—esophageal cancer	0.000199	0.0016	CcSEcCtD
Anastrozole—Discomfort—Methotrexate—esophageal cancer	0.000197	0.00158	CcSEcCtD
Anastrozole—Confusional state—Methotrexate—esophageal cancer	0.000192	0.00154	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.000191	0.00252	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.000191	0.00251	CbGpPWpGaD
Anastrozole—Anaphylactic shock—Methotrexate—esophageal cancer	0.000191	0.00153	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00019	0.0025	CbGpPWpGaD
Anastrozole—Infection—Methotrexate—esophageal cancer	0.00019	0.00152	CcSEcCtD
Anastrozole—Hypersensitivity—Capecitabine—esophageal cancer	0.000189	0.00152	CcSEcCtD
Anastrozole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000187	0.00246	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.000185	0.00243	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Methotrexate—esophageal cancer	0.000184	0.00148	CcSEcCtD
Anastrozole—Asthenia—Capecitabine—esophageal cancer	0.000184	0.00148	CcSEcCtD
Anastrozole—Anorexia—Methotrexate—esophageal cancer	0.000182	0.00146	CcSEcCtD
Anastrozole—Pruritus—Capecitabine—esophageal cancer	0.000181	0.00146	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000179	0.00235	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000178	0.00234	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000178	0.00234	CbGpPWpGaD
Anastrozole—Diarrhoea—Capecitabine—esophageal cancer	0.000175	0.00141	CcSEcCtD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000175	0.00231	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.000175	0.0023	CbGpPWpGaD
Anastrozole—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000174	0.0014	CcSEcCtD
Anastrozole—Insomnia—Methotrexate—esophageal cancer	0.000173	0.00139	CcSEcCtD
Anastrozole—Paraesthesia—Methotrexate—esophageal cancer	0.000171	0.00138	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—esophageal cancer	0.000171	0.00225	CbGpPWpGaD
Anastrozole—Dyspnoea—Methotrexate—esophageal cancer	0.00017	0.00137	CcSEcCtD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00017	0.00224	CbGpPWpGaD
Anastrozole—Somnolence—Methotrexate—esophageal cancer	0.00017	0.00136	CcSEcCtD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.00017	0.00223	CbGpPWpGaD
Anastrozole—Dizziness—Capecitabine—esophageal cancer	0.00017	0.00136	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000169	0.00223	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000169	0.00222	CbGpPWpGaD
Anastrozole—Dyspepsia—Methotrexate—esophageal cancer	0.000168	0.00135	CcSEcCtD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000168	0.00221	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.000168	0.00221	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000167	0.0022	CbGpPWpGaD
Anastrozole—Decreased appetite—Methotrexate—esophageal cancer	0.000166	0.00133	CcSEcCtD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000165	0.00217	CbGpPWpGaD
Anastrozole—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000165	0.00132	CcSEcCtD
Anastrozole—Fatigue—Methotrexate—esophageal cancer	0.000165	0.00132	CcSEcCtD
Anastrozole—CYP1A2—Phase II conjugation—GSTT1—esophageal cancer	0.000164	0.00216	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—ADH7—esophageal cancer	0.000163	0.00215	CbGpPWpGaD
Anastrozole—Pain—Methotrexate—esophageal cancer	0.000163	0.00131	CcSEcCtD
Anastrozole—Vomiting—Capecitabine—esophageal cancer	0.000163	0.00131	CcSEcCtD
Anastrozole—Rash—Capecitabine—esophageal cancer	0.000162	0.0013	CcSEcCtD
Anastrozole—Dermatitis—Capecitabine—esophageal cancer	0.000161	0.0013	CcSEcCtD
Anastrozole—Headache—Capecitabine—esophageal cancer	0.000161	0.00129	CcSEcCtD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000159	0.0021	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000158	0.00209	CbGpPWpGaD
Anastrozole—Feeling abnormal—Methotrexate—esophageal cancer	0.000157	0.00126	CcSEcCtD
Anastrozole—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000156	0.00125	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000156	0.00205	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000154	0.00202	CbGpPWpGaD
Anastrozole—Nausea—Capecitabine—esophageal cancer	0.000152	0.00122	CcSEcCtD
Anastrozole—Urticaria—Methotrexate—esophageal cancer	0.000152	0.00122	CcSEcCtD
Anastrozole—Abdominal pain—Methotrexate—esophageal cancer	0.000151	0.00121	CcSEcCtD
Anastrozole—Body temperature increased—Methotrexate—esophageal cancer	0.000151	0.00121	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000147	0.00193	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000145	0.00191	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000144	0.0019	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—ADH1B—esophageal cancer	0.000143	0.00189	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000143	0.00188	CbGpPWpGaD
Anastrozole—Hypersensitivity—Methotrexate—esophageal cancer	0.000141	0.00113	CcSEcCtD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000138	0.00181	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000137	0.0018	CbGpPWpGaD
Anastrozole—Asthenia—Methotrexate—esophageal cancer	0.000137	0.0011	CcSEcCtD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000135	0.00178	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000135	0.00178	CbGpPWpGaD
Anastrozole—Pruritus—Methotrexate—esophageal cancer	0.000135	0.00108	CcSEcCtD
Anastrozole—CYP1A2—Biological oxidations—CYP26A1—esophageal cancer	0.000133	0.00175	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000132	0.00173	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000131	0.00173	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000131	0.00172	CbGpPWpGaD
Anastrozole—Diarrhoea—Methotrexate—esophageal cancer	0.000131	0.00105	CcSEcCtD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000129	0.0017	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000127	0.00167	CbGpPWpGaD
Anastrozole—Dizziness—Methotrexate—esophageal cancer	0.000126	0.00101	CcSEcCtD
Anastrozole—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000126	0.00166	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000124	0.00163	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTO1—esophageal cancer	0.000124	0.00163	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000123	0.00162	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTO1—esophageal cancer	0.000122	0.00161	CbGpPWpGaD
Anastrozole—Vomiting—Methotrexate—esophageal cancer	0.000121	0.000974	CcSEcCtD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000121	0.00159	CbGpPWpGaD
Anastrozole—Rash—Methotrexate—esophageal cancer	0.00012	0.000966	CcSEcCtD
Anastrozole—Dermatitis—Methotrexate—esophageal cancer	0.00012	0.000965	CcSEcCtD
Anastrozole—Headache—Methotrexate—esophageal cancer	0.00012	0.00096	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000118	0.00155	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000115	0.00151	CbGpPWpGaD
Anastrozole—Nausea—Methotrexate—esophageal cancer	0.000113	0.00091	CcSEcCtD
Anastrozole—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000112	0.00148	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000111	0.00146	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000111	0.00146	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000111	0.00145	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000108	0.00143	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000107	0.0014	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000105	0.00139	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000105	0.00138	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000103	0.00135	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—BLVRB—esophageal cancer	0.000102	0.00134	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC52A3—esophageal cancer	0.000102	0.00134	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000101	0.00133	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—ALDH2—esophageal cancer	0.000101	0.00133	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	9.9e-05	0.0013	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTT1—esophageal cancer	9.6e-05	0.00126	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	9.56e-05	0.00126	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP2A6—esophageal cancer	9.49e-05	0.00125	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	9.43e-05	0.00124	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—PTGS2—esophageal cancer	9.27e-05	0.00122	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	9.14e-05	0.0012	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	9.14e-05	0.0012	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—PTGS1—esophageal cancer	9e-05	0.00118	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	8.95e-05	0.00118	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	8.83e-05	0.00116	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CA1—esophageal cancer	8.69e-05	0.00114	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC10A2—esophageal cancer	8.69e-05	0.00114	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	8.66e-05	0.00114	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	8.64e-05	0.00114	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	8.42e-05	0.00111	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	8.42e-05	0.00111	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	8.3e-05	0.00109	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	8.24e-05	0.00108	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—esophageal cancer	8.24e-05	0.00108	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CA2—esophageal cancer	7.95e-05	0.00105	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	7.79e-05	0.00103	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.77e-05	0.00102	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP1B1—esophageal cancer	7.65e-05	0.00101	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP1B1—esophageal cancer	7.55e-05	0.000993	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	7.41e-05	0.000975	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ADH7—esophageal cancer	7.39e-05	0.000972	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PLCE1—esophageal cancer	7.39e-05	0.000972	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	7.38e-05	0.000971	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	7.33e-05	0.000965	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	7.33e-05	0.000964	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP19A1—esophageal cancer	7.19e-05	0.000946	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	7.18e-05	0.000944	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	7.17e-05	0.000944	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP19A1—esophageal cancer	7.09e-05	0.000933	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	7.02e-05	0.000924	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—esophageal cancer	7.02e-05	0.000924	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	6.94e-05	0.000914	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ADH1B—esophageal cancer	6.48e-05	0.000853	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—TYMP—esophageal cancer	6.19e-05	0.000815	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP26A1—esophageal cancer	6.02e-05	0.000793	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	6.02e-05	0.000793	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	5.9e-05	0.000777	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALOX15—esophageal cancer	5.87e-05	0.000772	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	5.83e-05	0.000768	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	5.82e-05	0.000766	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTO1—esophageal cancer	5.6e-05	0.000737	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—TPI1—esophageal cancer	5.6e-05	0.000737	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	5.55e-05	0.00073	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	5.48e-05	0.00072	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALDOB—esophageal cancer	5.37e-05	0.000707	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GAPDH—esophageal cancer	5.17e-05	0.00068	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CRABP1—esophageal cancer	5.12e-05	0.000674	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.09e-05	0.00067	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.99e-05	0.000656	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GNG7—esophageal cancer	4.87e-05	0.000641	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ALDH2—esophageal cancer	4.57e-05	0.000601	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—BLVRB—esophageal cancer	4.52e-05	0.000595	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC52A3—esophageal cancer	4.52e-05	0.000595	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	4.35e-05	0.000572	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTT1—esophageal cancer	4.34e-05	0.000571	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP2A6—esophageal cancer	4.29e-05	0.000565	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.28e-05	0.000563	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ENO1—esophageal cancer	4.07e-05	0.000535	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS1—esophageal cancer	4.07e-05	0.000535	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.04e-05	0.000532	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PSME2—esophageal cancer	4.01e-05	0.000528	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PSME1—esophageal cancer	4.01e-05	0.000528	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC52A3—esophageal cancer	3.87e-05	0.000509	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—BLVRB—esophageal cancer	3.87e-05	0.000509	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CA1—esophageal cancer	3.85e-05	0.000506	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.85e-05	0.000506	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CA2—esophageal cancer	3.52e-05	0.000463	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.5e-05	0.000461	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1B1—esophageal cancer	3.46e-05	0.000455	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.46e-05	0.000455	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.44e-05	0.000452	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC10A2—esophageal cancer	3.29e-05	0.000432	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CA1—esophageal cancer	3.29e-05	0.000432	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ADH7—esophageal cancer	3.27e-05	0.00043	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.27e-05	0.00043	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.23e-05	0.000425	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CA2—esophageal cancer	3.01e-05	0.000396	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.98e-05	0.000392	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.98e-05	0.000392	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—HMOX1—esophageal cancer	2.97e-05	0.000391	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.94e-05	0.000387	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.91e-05	0.000383	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.87e-05	0.000377	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ABCB1—esophageal cancer	2.85e-05	0.000375	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PLCE1—esophageal cancer	2.79e-05	0.000368	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ADH7—esophageal cancer	2.79e-05	0.000368	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.76e-05	0.000363	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TYMP—esophageal cancer	2.74e-05	0.000361	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.67e-05	0.000351	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.6e-05	0.000342	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CA1—esophageal cancer	2.54e-05	0.000334	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.54e-05	0.000334	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TPI1—esophageal cancer	2.48e-05	0.000326	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.48e-05	0.000326	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ADH1B—esophageal cancer	2.45e-05	0.000322	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.38e-05	0.000313	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TYMP—esophageal cancer	2.34e-05	0.000308	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CA2—esophageal cancer	2.32e-05	0.000305	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.29e-05	0.000301	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP26A1—esophageal cancer	2.28e-05	0.0003	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.27e-05	0.000298	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALOX15—esophageal cancer	2.22e-05	0.000292	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.16e-05	0.000284	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ADH7—esophageal cancer	2.16e-05	0.000284	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GNG7—esophageal cancer	2.16e-05	0.000284	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.15e-05	0.000283	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TPI1—esophageal cancer	2.12e-05	0.000279	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTO1—esophageal cancer	2.12e-05	0.000279	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALDOB—esophageal cancer	2.03e-05	0.000267	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ALDH2—esophageal cancer	2.02e-05	0.000266	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.95e-05	0.000257	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.94e-05	0.000255	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.92e-05	0.000253	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CREBBP—esophageal cancer	1.9e-05	0.000251	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.9e-05	0.00025	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.89e-05	0.000249	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.89e-05	0.000249	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GNG7—esophageal cancer	1.84e-05	0.000242	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TYMP—esophageal cancer	1.81e-05	0.000238	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ENO1—esophageal cancer	1.8e-05	0.000237	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.8e-05	0.000237	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PSME1—esophageal cancer	1.77e-05	0.000233	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PSME2—esophageal cancer	1.77e-05	0.000233	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.76e-05	0.000231	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.73e-05	0.000227	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.71e-05	0.000225	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NOS3—esophageal cancer	1.71e-05	0.000224	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.64e-05	0.000216	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TPI1—esophageal cancer	1.63e-05	0.000215	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.63e-05	0.000215	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.62e-05	0.000214	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.62e-05	0.000213	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.57e-05	0.000206	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS2—esophageal cancer	1.56e-05	0.000205	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.55e-05	0.000204	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.54e-05	0.000202	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ENO1—esophageal cancer	1.54e-05	0.000202	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.53e-05	0.000201	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PSME2—esophageal cancer	1.52e-05	0.0002	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PSME1—esophageal cancer	1.52e-05	0.0002	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.51e-05	0.000198	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.49e-05	0.000197	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.44e-05	0.000189	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GNG7—esophageal cancer	1.42e-05	0.000187	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.33e-05	0.000175	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.32e-05	0.000174	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.31e-05	0.000173	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1B1—esophageal cancer	1.31e-05	0.000172	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—EP300—esophageal cancer	1.3e-05	0.000171	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.29e-05	0.00017	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.27e-05	0.000167	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.26e-05	0.000166	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.25e-05	0.000165	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP19A1—esophageal cancer	1.23e-05	0.000162	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ENO1—esophageal cancer	1.19e-05	0.000156	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.19e-05	0.000156	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PSME2—esophageal cancer	1.17e-05	0.000154	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PSME1—esophageal cancer	1.17e-05	0.000154	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.12e-05	0.000148	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.1e-05	0.000145	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.08e-05	0.000142	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.01e-05	0.000133	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—esophageal cancer	9.6e-06	0.000126	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.53e-06	0.000125	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.49e-06	0.000125	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.66e-06	0.000114	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CREBBP—esophageal cancer	8.43e-06	0.000111	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.32e-06	0.000109	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.15e-06	0.000107	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NOS3—esophageal cancer	7.55e-06	9.93e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CREBBP—esophageal cancer	7.2e-06	9.47e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.9e-06	9.08e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NOS3—esophageal cancer	6.45e-06	8.48e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS2—esophageal cancer	5.9e-06	7.76e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—EP300—esophageal cancer	5.74e-06	7.55e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.56e-06	7.31e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NOS3—esophageal cancer	4.98e-06	6.55e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—EP300—esophageal cancer	4.9e-06	6.45e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.55e-06	5.99e-05	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.25e-06	5.59e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—EP300—esophageal cancer	3.79e-06	4.98e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—esophageal cancer	3.63e-06	4.77e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.8e-06	3.68e-05	CbGpPWpGaD
